Iurlaro Mario, McInroy Gordon R, Burgess Heather E, Dean Wendy, Raiber Eun-Ang, Bachman Martin, Beraldi Dario, Balasubramanian Shankar, Reik Wolf
The Babraham Institute, Epigenetics Programme, Cambridge, CB22 3AT, UK.
Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK.
Genome Biol. 2016 Jun 29;17(1):141. doi: 10.1186/s13059-016-1001-5.
Genome-wide methylation of cytosine can be modulated in the presence of TET and thymine DNA glycosylase (TDG) enzymes. TET is able to oxidise 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC). TDG can excise the oxidative products 5fC and 5caC, initiating base excision repair. These modified bases are stable and detectable in the genome, suggesting that they could have epigenetic functions in their own right. However, functional investigation of the genome-wide distribution of 5fC has been restricted to cell culture-based systems, while its in vivo profile remains unknown.
Here, we describe the first analysis of the in vivo genome-wide profile of 5fC across a range of tissues from both wild-type and Tdg-deficient E11.5 mouse embryos. Changes in the formylation profile of cytosine upon depletion of TDG suggest TET/TDG-mediated active demethylation occurs preferentially at intron-exon boundaries and reveals a major role for TDG in shaping 5fC distribution at CpG islands. Moreover, we find that active enhancer regions specifically exhibit high levels of 5fC, resulting in characteristic tissue-diagnostic patterns, which suggest a role in embryonic development.
The tissue-specific distribution of 5fC can be regulated by the collective contribution of TET-mediated oxidation and excision by TDG. The in vivo profile of 5fC during embryonic development resembles that of embryonic stem cells, sharing key features including enrichment of 5fC in enhancer and intragenic regions. Additionally, by investigating mouse embryo 5fC profiles in a tissue-specific manner, we identify targeted enrichment at active enhancers involved in tissue development.
在TET和胸腺嘧啶DNA糖基化酶(TDG)存在的情况下,胞嘧啶的全基因组甲基化可被调节。TET能够将5-甲基胞嘧啶(5mC)氧化为5-羟甲基胞嘧啶(5hmC)、5-甲酰基胞嘧啶(5fC)和5-羧基胞嘧啶(5caC)。TDG可以切除氧化产物5fC和5caC,启动碱基切除修复。这些修饰碱基在基因组中是稳定且可检测的,这表明它们本身可能具有表观遗传功能。然而,对5fC全基因组分布的功能研究仅限于基于细胞培养的系统,其体内分布情况仍不清楚。
在这里,我们描述了对野生型和Tdg缺陷型E11.5小鼠胚胎一系列组织中5fC的体内全基因组分布的首次分析。TDG缺失后胞嘧啶甲酰化谱的变化表明,TET/TDG介导的主动去甲基化优先发生在内含子-外显子边界,并揭示了TDG在塑造CpG岛处5fC分布中的主要作用。此外,我们发现活性增强子区域特别表现出高水平的5fC,产生特征性的组织诊断模式,这表明其在胚胎发育中起作用。
5fC的组织特异性分布可由TET介导的氧化和TDG切除的共同作用来调节。胚胎发育过程中5fC的体内分布类似于胚胎干细胞,具有包括增强子和基因内区域中5fC富集在内的关键特征。此外,通过以组织特异性方式研究小鼠胚胎5fC谱,我们确定了参与组织发育的活性增强子处的靶向富集。